Arbor Biotechnologies nets $215m Series B
Arbor Biotechnologies, a biotechnology company, has raised $215 million in Series B financing.
Arbor Biotechnologies, a biotechnology company, has raised $215 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination